We all love to feel the exhilaration and loathe to feel the pain. However, a story stock such as SIRT with low float and limited liquidity, where the future is unlimited but the risks are high, tends to act in this schizophrenic manner. Throw in some venture capital sales of cheap stock and a lull in the news flow and the SIRT stock chart speaks for itself. The interesting thing about story stocks like SIRT is that when substantive good news comes along, sharp declines are often followed by steep climbs. One way to deal with this volatility is to own a long term core position and an equal trading position. Own no more in total than you can afford to lose and take the trading position off the table after a sharp rise. How sharp a rise? Who the hell KNOWS!!! That is the $501,000,000 question.
With SRT501 clinical trials from India due out any day now and with a little luck, we could see the chart turn upside down!!
On January 7th, SIRT is presenting at the 26th Annual JPMorgan Healthcare Conference. Clould this be the day they announce the SIRT501 clinical trial results?
Good luck and do your own due diligence.....and please visit our sponsors on this blog. Remember, immortality is expensive!
No comments:
Post a Comment